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and management in Australian general practice
Abstract
Cardiovascular absolute risk (CVAR) assessment (the probability of a cardiovascular event over 5 or 10 years
calculated from multiple risk factors) has been recommended as a means of more accurately tailoring
cardiovascular disease primary prevention strategies to the patient's risk level (1-4). Although the use of
CVAR assessment has been advocated for some time, the lack of an implementation strategy has hindered its
translation from guideline into practice both in Australia (5-8) and overseas (9-11). Our team has developed a
theoretical implementation model of CVAR assessment and management using multiple strategies to
encourage use (12,13).
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Experience in implementation of cardiovascular absolute risk assessment
and management in Australian general practice
To the Editor:
Cardiovascular absolute risk (CVAR) assess-
ment (the probability of a cardiovascular
event over 5 or 10 years calculated from mul-
tiple risk factors) has been recommended as a
means of more accurately tailoring cardiovas-
cular disease primary prevention strategies to
the patient’s risk level (1–4). Although the
use of CVAR assessment has been advocated
for some time, the lack of an implementation
strategy has hindered its translation from
guideline into practice both in Australia (5–8)
and overseas (9–11). Our team has developed
a theoretical implementation model of CVAR
assessment and management using multiple
strategies to encourage use (12,13).
We conducted a study in Sydney from
2006 to 2008, aiming to explore general prac-
titioners’ (GPs) experience of implementing
CVAR assessment and management, the feasi-
bility of our model and patients’ experience
of the impact of implementation in their doc-
tor’s practice.
We recruited five GPs and 25 patients to
participate. Based on the CVAR implementa-
tion model (12), GP intervention included
face-to-face training in their practices using
the CVAR assessment (electronic calculator
and paper-based chart) and management
guideline (3) and regular telephone support.
Patients completed a self-assessment question-
naire prior to seeing the GP. In the encoun-
ter, GPs assessed CVAR and then negotiated
treatment goals with patients, provided edu-
cation and pharmacotherapy, referred to
other providers and arranged follow up
according to the guideline. Participants were
also followed up for 3 months, with their
information collected by in-depth interviews
(GPs: face-to-face, patients: by phone) and
questionnaires. Qualitative data were analysed
using thematic analysis (14) in nvivo 7 soft-
ware (15) and quantitative data in spss soft-
ware (16). The Human Research Ethics
Committee of the University of New South
Wales gave ethical approval for this study.
Apart from one patient with a baseline
CVAR >30% who died of a heart attack during
3 month follow-up period, all other patients
completed the study. Before this study, none of
the participating GPs used CVAR assessment
routinely for their patients and two of them
had never assessed CVAR. By the end of the
study, they had all started using it in their rou-
tine practice and used the results more often to
help inform their medication and referral deci-
sions (especially to determine the threshold at
which to initiate medication treatment).
All GPs preferred the CVAR electronic cal-
culator to the CVAR paper chart because: it
was easy to use, took less time to use and
allowed them to modify risk factors and
recalculate CVAR. It allowed GPs to negotiate
treatment options with their patients by dem-
onstrating the outcomes for particular
actions, such as the control of blood pressure
or smoking cessation. Many patients also
reported liking to see on the screen the
impact of change in individual modifiable risk
factors (e.g. smoking, BP or lipids) on their
overall level of risk. Most GPs reported that
using an electronic calculator to assess CVAR
was an effective tool to help educate and
motivate patients to make lifestyle changes.
Most patients also reported that GPs mainly
used CVAR results to recommend changing
lifestyle rather than medications.
Both GPs and patients agreed that CVAR
consultation took a longer time (approxi-
mately 20 min) than usual. They generally
reported more involvement of each other in
the CVAR consultation. Many patients felt
that their GPs’ care in the CVAR consultation
was better than their usual care in terms of
consultation content and time.
In general, our results suggest that the
implementation experience of CVAR assess-
ment and management is successful, and the
CVAR implementation model is feasible.
Computer decision support programmes
are commonly used to improve the effec-
tiveness of the consultations (17). Other
research suggests that integrated electronic
calculators appeared more helpful than the
paper-based risk prediction charts (18). In
this study, GPs and patients preferred an
electronic CVAR calculator to a paper-based
chart. GPs especially liked the way the elec-
tronic calculator allowed them to visually
demonstrate improvement in patient risk in
response to management, as this positive
communication was also encouraging to
patients. In Australia, dissemination of
CVAR assessment tools has so far been in
paper-based format rather than an electronic
calculator. Thus, incorporation of the elec-
tronic CVAR calculator as a visual aid into
current practice software may be a necessary
condition for widespread adoption of CVAR
in general practice.
There is good evidence for a positive rela-
tionship between the duration of consulta-
tions and the quality of care (19–21). In this
study, GPs and patients generally reported
that approximately 20 min were spent on
CVAR assessment and management during
the consultation, allowing GPs and patients’
sufficient time to assess the CVAR and dis-
cuss the result and management. Another
research has found that after establishing that
a patient was ‘at risk’ of CHD, primary care
physicians reported spending an average of
16.5 min discussing risk factors and lifestyle
changes or treatment (22). This suggests
that a longer consultation with appropriate
remuneration may be necessary for conduct-
ing proper CVAR assessment and manage-
ment.
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How much vascular disease is reported by the UK media?
To the Editor:
We wonder if a new policy of media advocacy
could be undertaken by healthcare profession-
als to enhance the reportage of vascular dis-
ease. Medical issues covered by print media
must be generally ‘newsworthy’ – perhaps
related to innovations, celebrities and world
events. While newspapers are not primarily
involved in health education, they may have
an indirect role in how these issues are per-
ceived (1,2). Medical coverage may not be
very in-depth, but is usually in an easily com-
prehendible format, written at an appropriate
reading age for their readers (2).
Vascular disease is highly prevalent, with
large numbers of people affected directly or
indirectly. Vascular risk factors are the focus
of sustained health promotion and political
coverage, while recent medical innovations
(e.g. endovascular therapy) and celebrity ill-
ness (e.g. US Senator Bob Dole diagnosed
with an abdominal aortic aneurysm in 1998)
have received widespread reportage.
In order to estimate the reportage of vas-
cular disease in the UK, the top 10 newspa-
pers were assessed for 10 vascular terms
(claudication, aneurysm, angioplasty, deep
vein thrombosis, leg ulcers, vascular disease,
amputation, blocked arteries, varicose veins
and bypass surgery) over a 5-year period (via
their on-line articles search facilities) (3). A
total of 5713 articles were present (mean 10
articles per newspaper per month); the com-
monest terms were ‘amputation’ (1252 arti-
cles, 22%) and ‘bypass surgery’ (1072
articles, 19%). The least number of articles
related to ‘claudication’ (17 articles, 0.3%).
Tabloid newspapers (which represent 31.5%
of the daily UK circulation) reported 1266
vascular articles (22% total), while Broad-
sheet newspapers (9.7% UK circulation)
reported 4447 articles (78% total) (3,4).
While there is some overlap with the search
terms, this gives an estimate of the amount
of coverage vascular disease receives in the
media. As it was not possible to assess the
content of each individual article, we are
unsure if there is a genuine prevalence of
certain terms in the media, or if they are
secondary to world events (such as traumatic
amputation in areas of conflict).
We are not sure how much reportage of
vascular disease should exist in the media,
but ‘any publicity is good publicity’. If 6% of
the population is directly affected by periph-
eral vascular disease, should 6% of all news-
paper articles on health relate to this
condition? At present we suspect that this
level of reportage falls far below this. The
print media coverage should be consistent,
fair and relevant (5).
Health professionals, in conjunction with
public health officials and journalists could
form a partnership to ensure a co-ordinated
approach in how relevant medical information
is presented to the print media. This
collaboration would ensure better dissemina-
tion of patient education to the population
and hopefully enhance the background knowl-
edge of common medical conditions. This
new strategy would exist in conjunction with
the presentation of medical information by
traditional means (consultations and patient
information leaflets) and utilise a newspaper’s
own writing style and format to ensure opti-
mal uptake by readership (6). We agree with
previous hypotheses that ‘The media may be
the most important health information source
available to the general population’ and thus
we are keen to ensure that health professionals
can influence this resource (7).
James Williamson, David Hocken
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